GILD
Gilead Sciences Inc
Price:  
73.55 
USD
Volume:  
5,572,757.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Gilead EV/EBITDA

40.3%
Upside

As of 2024-02-26, the EV/EBITDA ratio of Gilead Sciences Inc (GILD) is 6.23. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Gilead's latest enterprise value is 83,218.24 mil USD. Gilead's TTM EBITDA according to its financial statements is 13,362.00 mil USD. Dividing these 2 quantities gives us the above Gilead EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 10.6x - 12.4x 11.4x
Forward P/E multiples 9.3x - 11.6x 9.8x
Fair Price 72.93 - 139.31 103.17
Upside -0.8% - 89.4% 40.3%
73.55 USD
Stock Price
103.17 USD
Fair Price

Gilead EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-02-26 16.24
2024-02-23 16.18
2024-02-22 16.01
2024-02-21 16.10
2024-02-20 15.85
2024-02-16 15.75
2024-02-15 16.14
2024-02-14 16.07
2024-02-13 16.18
2024-02-12 16.38
2024-02-09 16.21
2024-02-08 16.24
2024-02-07 16.37
2024-02-06 17.10
2024-02-05 16.88
2024-02-02 16.93
2024-02-01 17.19
2024-01-31 17.22
2024-01-30 17.30
2024-01-29 17.39
2024-01-26 17.49
2024-01-25 17.65
2024-01-24 17.50
2024-01-23 17.49
2024-01-22 17.25
2024-01-19 19.20
2024-01-18 19.01
2024-01-17 19.02
2024-01-16 18.92
2024-01-12 19.00
2024-01-11 18.79
2024-01-10 18.59
2024-01-09 18.93
2024-01-08 18.48
2024-01-05 18.33
2024-01-04 18.59
2024-01-03 18.37
2024-01-02 18.31
2023-12-29 17.82
2023-12-28 17.85
2023-12-27 17.68
2023-12-26 17.59
2023-12-22 17.52
2023-12-21 17.36
2023-12-20 17.29
2023-12-19 17.49
2023-12-18 17.49
2023-12-15 17.67
2023-12-14 17.99
2023-12-13 18.28